Drugs / Ropirinole
last change Aug 2016 re-read 3 minutes ago

Ropirinole

Developed for
Parkinson disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT02347059 Comparator Jan 2015 → Aug 2016 Parkinson disease University of Toronto Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ropirinole ClinicalTrials.gov intervention name — accepted as the source's own label NCT02347059 ↗